Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Advances in the Neurobiology of Mental Illness

WEBINAR

Only

FREE Event

Advances in the Neurobiology of Mental Illness

Monday, May 24, 2021, 10:15 AM - 5:10 PM EDT

Webinar

Presented By

The New York Academy of Sciences

 

Mental illness impacts one in four people worldwide, resulting in substantial health, social, and economic burdens. Emerging insights into the biological mechanisms underlying many psychiatric disorders offer hope that novel therapeutic interventions may alleviate disability associated with these diseases.

This symposium will provide a neutral forum for neurobiologists, psychiatrists, and psychopharmacologists across academic, clinical, industry, and government sectors to explore new scientific understanding of the neurobiological mechanisms of mental illnesses. Plenary presentations will include emerging research on how genetics, neuroimmunology, brain imaging, computational psychiatry, and behavior regulation contribute to understanding schizophrenia, major depression, and other diseases. Beyond basic science underlying these mental illness, the symposium will include discussion of potential therapeutic targets and avenues for translating the basic science into improved treatments.

Registration

Speakers

Alan Anticevic
Alan Anticevic, PhD

Yale School of Medicine

Deanna Barch
Deanna Barch, PhD

Washington University in St. Louis

Bill Martin, PhD
Bill Martin, PhD

The Janssen Pharmaceutical Companies of Johnson & Johnson

Patrick McGorry
Patrick D. McGorry, PhD

University of Melbourne

Benjamin Neale, PhD
Benjamin Neale, PhD

Broad Institute of MIT and Harvard,

Beth Stevens, PhD
Beth Stevens, PhD

Harvard Medical School, Boston Children’s Hospital, HHMI

Consuelo Walss-Bass
Consuelo Walss-Bass, PhD

University of Texas McGovern Medical School

Sponsor

Monday

May 24, 2021

10:15 AM

Welcome Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
10:30 AM

Historical Perspective on Biological Psychiatry

Speaker

Bill Martin, PhD
The Janssen Pharmaceutical Companies of Johnson & Johnson
11:10 AM

Patient-Derived Brain-Based Mechanistic Studies of Psychiatric Disorders

Speaker

Consuelo Walss-Bass, PhD
University of Texas McGovern Medical School
11:50 AM

Break

12:00 PM

Elucidating the Genetic Architecture of Psychiatric Disorders

Speaker

Benjamin Neale, PhD
Broad Institute of MIT and Harvard
12:40 PM

Quantifying the Brain-Behavioral Space across the Psychosis Spectrum for Neuroscience-Guided Therapeutic Target Selection

Speaker

Alan Anticevic, PhD
Yale School of Medicine
1:20 PM

Lunch break

2:10 PM

Mechanisms of Motivational and Cognitive Deficits in Psychiatric Illness

Speaker

Deanna Barch, PhD
Washington University in St. Louis
2:50 PM

The Role of Microglia in Serious Mental Illnesses

Speaker

Beth Stevens, PhD
Harvard Medical School, Boston Children’s Hospital, HHMI
3:30 PM

Break

3:50 PM

Clinical Staging in Psychiatry: Making Diagnosis Work for Patients, Clinicians and Researchers

Speaker

Patrick D. McGorry, PhD
University of Melbourne
4:30 PM

Panel Discussion: The Future of Neuroscience R&D: Deepening Insights into Patients through Conceptual and Scientific Advances

Speakers

Moderator: Bill Martin, PhD
The Janssen Pharmaceutical Companies of Johnson & Johnson
Patrick D. McGorry, PhD
University of Melbourne
Benjamin Neale, PhD
Broad Institute of MIT and Harvard​
Beth Stevens, PhD
Harvard Medical School, Boston Children’s Hospital, HHMI
5:15 PM

Closing Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
5:20 PM

Symposium Adjourns